Risk of non-melanoma skin cancer in patients with chronic kidney disease and its relationship to uraemic pruritus

19Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

This study investigated the risk of non-melanoma skin cancer (NMSC) in pre-dialysis patients with chronic kidney disease (CKD) and explored associated risk factors. A population-based cohort of 1,515,858 Taiwanese CKD patients was included. The standardized incidence ratio (SIR) for incident NMSC was determined. Compared with the general population, a 1.14- fold risk of NMSC was found in the CKD cohort. NMSC risk was significant in patients with pre-dialysis stage 5 CKD and anaemia (1.48-fold), and in those with uraemic pruritus after long-term antihistamine treatment (1.38-fold). A higher SIR for NMSC was found in younger patients with CKD (age < 70 years, 1.34-fold; age 20–39 years, 1.63-fold), stage 5 CKD with anaemia (age < 70 years, 2.09-fold), and uraemic pruritus (age <70 years, 2.22-fold). Pre-dialysis patients with CKD are at higher risk of NMSC, especially those with advanced-stage CKD, and those with uraemic pruritus.

Cite

CITATION STYLE

APA

Wang, C. C., Tang, C. H., Huang, S. Y., Huang, K. C., & Sue, Y. M. (2017). Risk of non-melanoma skin cancer in patients with chronic kidney disease and its relationship to uraemic pruritus. Acta Dermato-Venereologica, 97(10), 1230–1234. https://doi.org/10.2340/00015555-2762

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free